Home » Programs » Rosenman Founders » Blythe Karow

Blythe Karow, Chief Commercialization Officer, NueroGeneces

Blythe Karow is a medical device entrepreneur with 20+ years of demonstrated ability to develop innovative and cost-effective solutions for enhancing competitiveness, manage products from conception to market launch, and identify & evaluate acquisition, licensing, and market growth opportunities. Her main strength is the ability to quickly analyze complex business issues and devise customer-centric solutions. Therapeutic areas include neuromodulation, wound care, CRM, cardiovascular, image-guided interventions, women’s health, dermatology, spinal, orthopedic, diagnostics, etc.